Literature DB >> 22157320

Macrophages: contributors to allograft dysfunction, repair, or innocent bystanders?

Roslyn B Mannon1.   

Abstract

PURPOSE OF REVIEW: Macrophages are members of the innate immune response. However, their role in the adaptive immune response is not known. The purpose of this review is to highlight our current understanding of macrophage structure and function and how they may participate in allograft injury. RECENT
FINDINGS: Studies in acute kidney injury models identify macrophages as key mediators of inflammatory injury, while more recent studies indicate that they may play a reparative role, depending on phenotype - M1 or M2 type macrophages. Mregs, generated in vitro, appear to have immune suppressive abilities and a unique phenotype. In solid-organ transplant, the emphasis of studies has been on acute or chronic injury. These data are derived from animal models using depletion of macrophages or antagonizing their activation and inflammatory responses. The relative contribution of macrophage phenotype in transplantation has not been explored.
SUMMARY: These studies suggest that macrophages play an injurious role in acute cellular allograft rejection, as well as in chronic injury. Infiltration of an allograft with macrophages is also associated with worse graft function and poor prognosis. Further studies are needed to understand the mechanisms of macrophage-mediated injury, explore their potential reparative role, and determine if they or their functional products are biomarkers of poor graft outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22157320      PMCID: PMC3319132          DOI: 10.1097/MOT.0b013e32834ee5b6

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  44 in total

1.  Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.

Authors:  H J Gröne; C Weber; K S Weber; E F Gröne; T Rabelink; C M Klier; T N Wells; A E Proudfood; D Schlöndorff; P J Nelson
Journal:  FASEB J       Date:  1999-08       Impact factor: 5.191

2.  Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection.

Authors:  Alex B Magil; Kathryn Tinckam
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

3.  Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice.

Authors:  A Fox; M Koulmanda; T E Mandel; N van Rooijen; L C Harrison
Journal:  Transplantation       Date:  1998-12-15       Impact factor: 4.939

4.  Chronic rejection of mouse kidney allografts.

Authors:  R B Mannon; J B Kopp; P Ruiz; R Griffiths; M Bustos; J L Platt; P E Klotman; T M Coffman
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

5.  Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.

Authors:  Yuan-Ji Day; Liping Huang; Hong Ye; Joel Linden; Mark D Okusa
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-23

6.  Macrophages act as effectors of tissue damage in acute renal allograft rejection.

Authors:  Matthew D Jose; Yohei Ikezumi; Nico van Rooijen; Robert C Atkins; Steven J Chadban
Journal:  Transplantation       Date:  2003-10-15       Impact factor: 4.939

7.  Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Authors:  Allan D Kirk; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Steven C Hoffmann; Robert L Kampen; Linda K Cendales; Douglas K Tadaki; David M Harlan; S John Swanson
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

8.  Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Qunrui Ye; Rongxiang Han; Martin E Dorf; William A Kuziel; Barrett J Rollins; Lieping Chen; Wayne W Hancock
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Identification of platelet-derived growth factor A and B chains in human renal vascular rejection.

Authors:  C E Alpers; C L Davis; D Barr; C L Marsh; K L Hudkins
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

10.  Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts.

Authors:  W W Hancock; N M Thomson; R C Atkins
Journal:  Transplantation       Date:  1983-05       Impact factor: 4.939

View more
  41 in total

1.  Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.

Authors:  Xuedong Wei; Nicole M Valenzuela; Maura Rossetti; Rebecca A Sosa; Jessica Nevarez-Mejia; Gregory A Fishbein; Arend Mulder; Jayeeta Dhar; Karen S Keslar; William M Baldwin; Robert L Fairchild; Jianquan Hou; Elaine F Reed
Journal:  Am J Transplant       Date:  2020-05-22       Impact factor: 8.086

2.  Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.

Authors:  Jason M Zimmerer; Xin L Liu; Alecia Blaszczak; Christina L Avila; Thomas A Pham; Robert T Warren; Ginny L Bumgardner
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

3.  Harnessing Expressed Single Nucleotide Variation and Single Cell RNA Sequencing To Define Immune Cell Chimerism in the Rejecting Kidney Transplant.

Authors:  Andrew F Malone; Haojia Wu; Catrina Fronick; Robert Fulton; Joseph P Gaut; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 10.121

4.  Graft-derived CCL2 increases graft injury during antibody-mediated rejection of cardiac allografts.

Authors:  T Abe; C A Su; S Iida; W M Baldwin; N Nonomura; S Takahara; R L Fairchild
Journal:  Am J Transplant       Date:  2014-08       Impact factor: 8.086

Review 5.  Single-Cell Transcriptomics of a Human Kidney Allograft Biopsy Specimen Defines a Diverse Inflammatory Response.

Authors:  Haojia Wu; Andrew F Malone; Erinn L Donnelly; Yuhei Kirita; Kohei Uchimura; Sai M Ramakrishnan; Joseph P Gaut; Benjamin D Humphreys
Journal:  J Am Soc Nephrol       Date:  2018-07-06       Impact factor: 10.121

6.  Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.

Authors:  Yue Zhao; Song Chen; Peixiang Lan; Chenglin Wu; Yaling Dou; Xiang Xiao; Zhiqiang Zhang; Laurie Minze; Xiaoshun He; Wenhao Chen; Xian C Li
Journal:  Am J Transplant       Date:  2017-11-23       Impact factor: 8.086

7.  Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.

Authors:  Yianzhu Liu; Wenhao Chen; Chenglin Wu; Laurie J Minze; Jacek Z Kubiak; Xian C Li; Malgorzata Kloc; Rafik M Ghobrial
Journal:  J Heart Lung Transplant       Date:  2016-08-20       Impact factor: 10.247

8.  Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation.

Authors:  Yijen L Wu; Qing Ye; Danielle F Eytan; Li Liu; Bedda L Rosario; T Kevin Hitchens; Fang-Cheng Yeh; Nico Rooijen van; Chien Ho
Journal:  Circ Cardiovasc Imaging       Date:  2013-10-04       Impact factor: 7.792

9.  Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.

Authors:  C Wu; Y Zhao; X Xiao; Y Fan; M Kloc; W Liu; R M Ghobrial; P Lan; X He; X C Li
Journal:  Am J Transplant       Date:  2016-05-02       Impact factor: 8.086

10.  Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Takeshi Yamada; Hiroya Hasegawa; Utako Kaneko; Masanori Hara; Toshio Yanagihara; David J Nikolic-Paterson; Akihiko Saitoh
Journal:  Pediatr Nephrol       Date:  2014-12-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.